Author Archives: admin

KIT inhibition by Gleevec (imatinib) for severe asthma

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The Weekly Summary

May 15th – May 21st                                 2017 In general news, moderate candidate Rouhini was re-elected in Iran despite anger brewing

Posted in - The Weekly Summary | Leave a comment

The Healthcare Channel hits 10

 February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming

Posted in - Opinion | 1 Comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

The Weekly Summary

May 8th – May 14th                                 2017 In general news, North Korea launched another provocative test missile. A global computer virus

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

May 1st – May 7th                                 2017  In general news, France elected moderate Macaron instead of FREXIT proponent Le Pen. In the

Posted in - The Weekly Summary | Leave a comment

Trump made a big mistake wading into the quagmire of healthcare

Is President Obama foreseeing the future here and having a laugh? May 7, 2017- Opinion by Steven E. Greer, MD I watched Face the Nation and the news coverage of Friday town hall meetings. Mick Mulvaney was

Posted in - Opinion, CMS, Congress | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - Generics, FDA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the

Posted in - Policy, FDA | 1 Comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

The Weekly Summary

April 24th – April 30th                                 2017 In general news, President Trump warned North Korea again after they test fired a missile.

Posted in - The Weekly Summary | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Why Indian Point nuclear power plant needs to be shut down

April 29, 2017- by Steven E. Greer, MD I have long been a critic of the overuse of CT-scans due to the dangers of radiation. I’m not sure why,

Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Obstetrics and Gynecology, Radiology, UC San Francisco | Leave a comment

The Weekly Summary

April 17th – April 23rd                                 2017 In general news, Paris suffered yet another radical Islamic attack when a man shot and killed a police officer.

Posted in - The Weekly Summary | Leave a comment